Arvind Fashions is perfectly positioned for valuation re-rating. It has a portfolio of marquee brands like Tommy Hilfiger & Calvin Klein, lean...
Analysis of 23 “CUBs” i.e quality small-cap cos in the early stages of their growth cycle & with robust long-term growth potential. Despite low...
Nuvama hosted a conf on emerging cos (small and micro-cap stocks) & has issued a research report containing crisp data on 101 such cos. Report...
Royal Orchid Hotels will benefit from favourable demand-supply dynamics. Revenue/EBITDA to clock 29%/18% CAGR over FY23–25. Growth expected to...
Elecon Engineering has strong execution, delivery & margin. Capex demand is robust. Company is riding the wave of sector tailwinds. FY24 Revenue...
Gati is a leading multi-modal express logistics player. It is turning over a new leaf with an overhaul of operations & management. Asset light...
Kilpest's molecular diagnostics business is a niche segment with strong potential. Market size is Rs 300+cr with huge growth potential. It has...
BETA DRUGS is well placed to capitalise on growth opportunities in the oncology drugs segment. It has a healthy Balance Sheet. Average RoE in past...
Atarco acquisition is a win-win deal for Gokex. it will gain duty free access to the US & European markets. The acquisition is at a reasonable...
CIE is a MNC with 65.7% promoter holding. Its robust business model presents promising growth prospects. The stock is trading at an attractive...
Astral is a consistent quality performer & compounding story. It is superior in every respect with strong cash flow & net debt-free Balance Sheet....
Separate names with a comma.
